| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $159.9M | -3.9% | +14.7% |
| R&D Expense | $216.2M | +31.2% | +27.1% |
| SG&A Expense | $86.6M | -0.0% | +7.8% |
| Operating Income | -$170.9M | -58.4% | -29.5% |
| Pre-tax Income | -$179.5M | -57.5% | -34.8% |
| Income Tax | $873K | -7.8% | +188.1% |
| Net Income | -$180.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $202.5M | +14.9% | +34.5% |
| Accounts Receivable | $112.5M | -9.6% | +20.6% |
| Inventory | $52.2M | +12.3% | +20.5% |
| Current Assets | $643.2M | -10.6% | -19.6% |
| Total Assets | $1.19B | -8.9% | -22.6% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$366.2M | — | — |
| Capital Expenditures | $5.1M | — | — |
| Investing Cash Flow | $308.2M | — | — |
| Financing Cash Flow | $83.8M | — | — |
| Free Cash Flow | -$371.2M | — | — |
| -56.9% |
| -35.1% |
| EPS (Basic) | -$1.81 | -54.7% | -29.3% |
| EPS (Diluted) | -$1.81 | -54.7% | -29.3% |
| $340.0M |
| +16.0% |
| +19.3% |
| Total Liabilities | $1.17B | +2.3% | -0.9% |
| Stockholders' Equity | $9.2M | -93.9% | -97.4% |